Kite Pharma Inc. buy melinda
Start price
02.04.16
/
50%
€44.22
Target price
08.08.16
€57.73
Performance (%)
19.54%
End price
08.08.16
€52.86
Summary
This prediction ended on 08.08.16 with a price of €52.86. The prediction had a final performance of 19.54%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kite Pharma Inc. | - | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by melinda for this prediction
In the thread Kite Pharma Inc. diskutieren
Stier
Kite Pharma, Inc. betreibt als klinisches Praktikum Biotechnologie - Unternehmen, qui in der Entwicklung und Vermarktung neuartiger Krebs immunotherapeutic Produkte mit Fokus auf technisch autologe T - Zell - Therapeutika beschäftigt Gezielte , um verschiedene Arten von Tumor.
(Vom Mitglied beendet)
Stopped prediction by melinda for Kite Pharma Inc.
Kite Pharma Inc.
Start price
Target price
Perf. (%)
€160.57
31.08.17
31.08.17
€166.87
05.10.17
05.10.17
0.99%
05.10.17
05.10.17
